BROS vs CURX · P/E 105, rev $1.02B vs $8.9M cap
Dutch Bros Inc (BROS) versus Curanex Pharmaceuticals Inc Common Stock (CURX) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Latest reported BROS revenue for 2026-06-30 was $1.02B. Net income was $53.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
CURX does not have a complete income-statement cache yet.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. CURX currently screens at market cap $8.9M.
Not investment advice. Open the BROS and CURX stock pages for the full models.
Not investment advice.